Opendata, web and dolomites

MIRIADE SIGNED

Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "MIRIADE" data sheet

The following table provides information about the project.

Coordinator
STICHTING VUMC 

Organization address
address: DE BOELELAAN 1117
city: AMSTERDAM
postcode: 1081 HV
website: www.vumc.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 4˙034˙564 €
 EC max contribution 4˙034˙564 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    STICHTING VUMC NL (AMSTERDAM) coordinator 265˙619.00
2    STICHTING VU NL (AMSTERDAM) participant 1˙062˙479.00
3    ADX NEUROSCIENCES BE (Gent) participant 512˙640.00
4    LGC LIMITED UK (TEDDINGTON) participant 303˙172.00
5    GOETEBORGS UNIVERSITET SE (GOETEBORG) participant 281˙982.00
6    KUNGLIGA TEKNISKA HOEGSKOLAN SE (STOCKHOLM) participant 281˙982.00
7    F. HOFFMANN-LA ROCHE AG CH (BASEL) participant 281˙276.00
8    CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER FR (MONTPELLIER) participant 274˙802.00
9    UNIVERSITA DEGLI STUDI DI PERUGIA IT (PERUGIA) participant 261˙499.00
10    UNIVERSITE DU LUXEMBOURG LU (ESCH-SUR-ALZETTE) participant 256˙320.00
11    UNIVERSITAET ULM DE (ULM) participant 252˙788.00

Map

 Project objective

Dementia is currently diagnosed largely based on cognitive decline, while pathology starts years before symptom onset. To make progress in the development of effective drugs for dementia, there is an urgent need for biomarkers to enable precision health: for early and specific diagnosis and objective monitoring of disease progression.

With its multidisciplinary team of scientists from academia, industry, and patient organisations, MIRIADE aims to train a new generation of scientists able to optimise and accelerate development of novel biomarkers for dementia. MIRIADE will integrate biomarker discovery data from multiple platforms and develop a Dementia Disease Map to enhance biomarker identification (WP1). We will develop assays for prioritized biomarkers (WP2), and selected markers will be clinically validated (WP3). We will study pre-analytical stability and validate against regulatory requirements (WP4) and develop a roadmap for optimal biomarker development (WP5). MIRIADE will thus establish an innovative biomarker-focussed cross-sectoral research and training programme that will equip ESRs with a unique combination of skills in big data analysis, biomarker assay development, innovation management, and a thorough understanding of medical needs. This programme will provide a new task force of scientists that are optimally trained to the accelerate the biomarker development for dementias and able to progress effective biomarker tools to the clinic.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIRIADE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MIRIADE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

NL4XAI (2019)

Interactive Natural Language Technology for Explainable Artificial Intelligence

Read More  

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

SuperCol (2020)

SuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications

Read More